Are early and late cardiovascular risk markers in women with polycystic ovary syndrome increased with concomitant non-alcoholic steatohepatitis and can this be modified with liraglutide?
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2014
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 09 Oct 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2009-015927-94).
- 31 Dec 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 25 May 2012 New trial record